|
|
Fifth Target Batch
For the fifth round of Target Selection (Batch05), we focused our efforts on hand selecting 196 additional drug candidates from our 15 bacterial and eukaryotic default organisms. Through literature survey, internal consortium discussions and communications with top pharmaceutical and research investigators, we identified 196 targets in the representative sequenced genomes from the following 15 species and strains currently being utilized for internal batch01, 02 and 03 efforts: Anaplasma phagocytophilum HZ (AnphA), Babesia bovis T2Bo (BaboA), Bartonella henselae Houston-1 (BaheA), Borrelia burgdorferi B31 (BobuA), Brucella melitensis biovar abortus 2308 (BrabA), Burkholderia pseudomallei 1710b (BupsA), Coccidioides immitis RS (CoimA), Cryptosporidium parvum Iowa II (CrpaA), Ehrlichia chaffeensis Arkansas (EhchA), Encephalitozoon cuniculi GB-M1 (EncuA), Entamoeba histolytica HM-1:IMSS (EnhiA), Giardia lamblia ATCC_50803 (GilaA), Mycobacterium tuberculosis H37Rv (MytuD), Rickettsia prowazekii MadridE (RiprA), Toxoplasma gondii ME49 (TogoA).
|
You can access a spreadsheet listing these 196 targets by clicking on the thumbnail below. For a key to link Target IDs to Organism, please see the table here.
|
